Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Epirubicin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 4 Resectable HER2-positive Breast Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-Muscle Invasive Bladder Neoplasms 1 Lymphoma, B-Cell, Marginal Zone 1 Inflammatory Breast Neoplasms 1 Carcinoma, Adenoid Cystic 1

Interventions

Biopsy 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 ruxolitinib 3 X-Rays 3 Vincristine 3 10-propargyl-10-deazaaminopterin 3 venetoclax 2 tazemetostat 2 sodium-iodide symporter 2 pembrolizumab 2 duvelisib 2 cemiplimab 2 belinostat 2 Prednisone 2 Photons 2 Nivolumab 2 Ipilimumab 2 Immunoglobulin G 2 Etoposide 2 Doxorubicin 2 Disulfides 2 CTLA-4 Antigen 2 Azacitidine 2 zanubrutinib 1 talimogene laherparepvec 1 nelarabine 1 mogamulizumab 1 enasidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡